Eventi

Inet lecture - The business model of big pharma

introduced by Roberto Mania

U.S. pharmaceutical companies argue that high profits from high drug prices fund innovative R&D spending. Yet these companies allocate profits from high drug prices to massive stock repurchases to boost their stock prices, while restricting access to medicines and undermining medical innovation.
Visions
traduzione simultanea

Quando

04 10:00

domenica 04 giugno 2017
10:00 - 11:15

Dove